Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its ...

Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

Orforglibron, a pill form of GLP-1 weight loss injections like Ozempic and Mounjaro, is undergoing clinical trials. Drugmaker Eli Lilly said the first trial showed similar weight loss and diabetes ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

Illegal "weight loss injections" with dirty needles are being sold over social media and sent to people in Northern Ireland, a BBC investigation has found. BBC News NI made test purchases of ...

Side effects on the tablet were similar to the weight-loss injections, with about one in four people experiencing diarrhoea and one in six suffering nausea. Two in three adults in Britain are ...

It competes with Lilly's injectable tirzepatide — sold under the brand names Mounjaro for obesity and Zepbound for weight loss — which mimics GLP-1 and a second hormone called GIP, and has ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

By Gina Kolata and Rebecca Robbins A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and ...